Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1Phase 4 1

Status

Unknown 4Completed 4Recruiting 3Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Mantle-Cell 1Lymphoma 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × R-CHOP protocol × Clear all
NCT02633137 2024-08-30

Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
49 enrolled 8 charts
Lymphoid

Lymphoma, Mantle-Cell

NCT00268853 2024-05-30

RAPID

CTI BioPharma

Phase 2 Completed
124 enrolled 13 charts
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT02660710 2022-10-28

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
39 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02890602 2020-02-20

Erythropoietin for Management of Anemia Caused by Chemotherapy

Kosin University Gospel Hospital

Phase 2 Completed
53 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡